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Diminished Neural and Cognitive Responses to Facial
Expressions of Disgust in Patients with Psoriasis:
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Clare L. Isaacs4, Ian M. Anderson2, Helen L. Richards3, J.F. William Deakin2, Donal G. Fortune5 and
Christopher E.M. Griffiths1
Psoriasis produces significant psychosocial disability; however, little is understood about the neurocognitive
mechanisms that mediate the adverse consequences of the social stigma associated with visible skin lesions,
such as disgusted facial expressions of others. Both the feeling of disgust and the observation of disgust in
others are known to activate the insula cortex. We investigated whether the social impact of psoriasis is
associated with altered cognitive processing of disgust using (i) a covert recognition of faces task conducted
using functional magnetic resonance imaging (fMRI) and (ii) the facial expression recognition task (FERT), a
decision-making task, conducted outside the scanner to assess the ability to recognize overtly different
intensities of disgust. Thirteen right-handed male patients with psoriasis and 13 age-matched male controls
were included. In the fMRI study, psoriasis patients had significantly (Po0.005) smaller signal responses to
disgusted faces in the bilateral insular cortex compared with healthy controls. These data were corroborated by
FERT, in that patients were less able than controls to identify all intensities of disgust tested. We hypothesize
that patients with psoriasis, in this case male patients, develop a coping mechanism to protect them from
stressful emotional responses by blocking the processing of disgusted facial expressions.
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INTRODUCTION
Psoriasis has a significant negative impact on the physical
and psychosocial well-being of those it afflicts comparable
with that of patients with cancer, heart disease, or diabetes
mellitus (Rapp et al., 1999).
The ‘‘brain–skin axis’’ is emerging as a useful concept in
understanding how skin disease produces psychosocial
disability and how stressful life events may exacerbate
inflammatory skin disease (Bremner et al., 2005; Paus et al.,
2006; reviewed in Sternberg, 2006). However, little is known
about the neurocognitive mechanisms that mediate the
adverse social and psychological consequences of the stigma
and humiliation associated with visible skin lesions (Wahl
et al., 2002; reviewed in De Korte et al., 2004). Our earlier
work has shown that psoriasis patients, relative to controls,
commonly believe that they will be evaluated solely on the
basis of their skin and they use anticipatory and avoidance
social coping behaviors (Fortune et al., 1997, 2003). We
hypothesize that a key cue is the perception of subtle degrees
of disgust in the expression of others. It is well known that
different facial emotions evoke overlapping patterns of neural
activity in the ventral visual processing stream, in the
amygdala, and the ventral frontal cortex, with additional
areas specifically engaged by particular emotions (Anderson
et al., 2007). Expressions of disgust are notable in activating
the insula cortex, part of the interoceptive gustatory pathway
(Phillips et al., 1997).
Here we investigate whether the social impact of psoriasis
is associated with altered cognitive processing of the
expression of disgust. In this preliminary study, we focused
on male patients only, as responses to facial emotions may be
confounded by gender in a mixed group, making interpreta-
tion difficult in a small sample. We used two methodologies:
(i) a task to assess covert recognition of faces conducted in
conjunction with functional magnetic resonance imaging
(fMRI) to determine the blood oxygenation level-dependent
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(BOLD) response in the insula and (ii) the facial expression
recognition task (FERT; Harmer et al., 2001), a decision-
making task, conducted outside the scanner to assess the
ability to recognize overtly, facial expressions of disgust at
different intensities.
RESULTS
Participant characteristics
Thirteen right-handed male patients (mean age: 35.8±2.3
years; range: 18–45) with a dermatologist-confirmed diag-
nosis of chronic plaque psoriasis (mean Psoriasis Area and
Severity Index (PASI): 5.3±3.6; range: 1.1–12.2) and 13 age-
matched right-handed male controls (mean age: 31.2±2.1
years; range: 19–43) with no history of skin disease
participated in the study between July 2006 and August
2007. Patients were recruited irrespective of current psoriasis
treatment that included topical treatment (n¼ 4), methotrex-
ate (n¼5), acitretin (n¼ 1), infliximab (n¼1), and no
treatment (n¼2). The psoriasis and control groups were
matched for age using a 5-year age band on either side of the
matched patient and the groups were well balanced.
Psychometric data
Fear of negative evaluation. In order to discriminate
between patients with social anxiety and both non-patient
controls and patients with other anxiety disorders, potential
volunteers who scored 420 out of a total of 30 (n¼5) were
not included in the study (Watson and Friend, 1969;
Rodebaugh et al., 2004). We observed similar mean scores
in both controls (8.3±1.4) and patients with psoriasis
(8.8±1.7).
Hospital anxiety and depression scale. Participants did not
have a psychiatric diagnosis and scored below cutoffs for
clinical anxiety and depression.
The mean Hospital Anxiety and Depression Scale (HADS)
anxiety score was 5.15±0.77 (range: 0–11) for the control
group and 7.08±0.91 (range: 2–14) for the psoriasis group.
Although there was a trend of increased anxiety scores in the
patient group, there was no significant statistical difference
between the two groups (P¼ 0.12; 95% confidence interval
(95% CI): 4.38 to 0.53).
The mean HADS depression score was 2.77±0.66 (range:
0–8) for the control group and 3.69±0.60 (range: 0–7) for the
psoriasis group. Similarly, there was no statistically significant
difference between the groups (P¼0.32; 95%CI:2.78 to 0.92).
Visual analog scale. Participants used a linear visual analog
scale (VAS) to record the amount of anxiety experienced at
baseline and post-testing in the scanner. This scale ranged
from 0 (‘‘not at all’’) to 100 (‘‘very much’’). There was a
significant (P¼ 0.03; 95% CI: 0.6–14.1) reduction of mean
VAS score from baseline in controls. In contrast, a non-
significant (P¼0.09; 95% CI: 1.6 to 18.5) reduction of
mean VAS score from baseline in the patients with psoriasis
was observed. The difference between the groups in terms of
mean change in VAS scores was not significant (Table 1).
These data suggest that anxiety prompted by anticipation was
allayed once the study was completed.
fMRI data
Patients have diminished response to facial expressions of
disgust. The pattern of BOLD responses to disgusted
compared with neutral faces in patients and controls
combined was consistent with earlier studies (Anderson
et al., 2007; reviewed in Posamentier and Abdi, 2003).
Bilateral responses occurred in the inferior frontal cortex;
insula, temporal and occipital cortices; and the putamen
(Table 2). The effect of disgusted facial expressions, as
compared with neutral facial expressions, across both
patients and controls produced more widespread activation
than fearful facial expressions (Tables 2 and 3).
Our key hypothesis was with regard to the differences
between patients and controls. Between-group comparisons
showed significantly attenuated BOLD response in the
bilateral insula of psoriasis patients compared with that of
controls (Table 2; Figure 1).
Patients and controls have similar response to facial
expressions of fear. The main effect of fearful faces com-
pared with neutral faces across both groups bilaterally
activated amygdalae and lateral orbitofrontal cortex, and
temporal and occipital cortices. There was no signifi-
cant difference between the two groups, suggesting that
the difference associated with disgust is specific to that
emotion.
FERT. These fMRI data were corroborated by FERT, which
showed that patients are less able than controls (odds ratio,
(95% CI): 0.4, (0.2–0.81); P¼ 0.017) to identify all intensities
of disgust tested (Figure 2). There was no intergroup differ-
ence in terms of processing of fear (0.98, (0.59–1.63);
P¼0.93) or sadness (1.15, (0.6–2.20); P¼ 0.67).
Table 1. VAS scores recorded by controls (n=12) and patients with psoriasis (n=12)
Baseline1 Post-fMRI1 Mean change (baseline–post-fMRI)1 Difference: controls–psoriasis patients (95% CI)2 P-value3
Controls 17.4±2.54 11±3.14 7.4±3.0 1.1 (10.6 to 12.7) 0.9
Psoriasis 19.2±4.64 9.9±3.34 8.4±4.6
CI, confidence interval; fMRI, functional magnetic resonance imaging; VAS, visual analog scale.
1Mean±SEM.
2Difference between controls and patients with psoriasis in terms of change in mean VAS scores from baseline.
3P-values were obtained using an independent two-sided t-test (equal variances not assumed).
4n varies from n¼11 to n¼ 12 due to a few missing data values.
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DISCUSSION
To the best of our knowledge, this is the first study to use fMRI
to investigate the effect of aversive facial expressions on
patients with psoriasis. We found significantly reduced
response in the insula cortex of patients compared with
controls when observing disgusted faces. This was accom-
panied by a behavioral deficit in detecting disgusted emotion
as measured by the FERT task. These effects were specific to
disgust; patients did not differ from controls in their brain
response to or recognition of fearful faces.
In both controls and patients, responses to disgusted and
fearful faces were associated with BOLD signal responses in a
network of brain regions consistent with other reports in the
literature (reviewed in Posamentier and Abdi, 2003). The
magnitudes of signal changes we observed were also
consistent with earlier studies in controls (Del-Ben et al.,
2005) and in other patient groups (Surguladze et al., 2005).
Consistent with the literature, the insula response was
associated with response to disgust but not to fear. The
insula has therefore been postulated as a key region of the
Table 2. Maximally activated voxels in areas in which significant evoked activity was related to covert recognition
of disgusted faces blocks compared with neutral faces blocks
Main effect (controls + patients) Controls–patients
MNI coordinates (mm) MNI coordinates (mm)
Region BA LR kE Z-score x y z Z-score x y z
Inferior frontal gyrus 47 L 96 4.21 47 34 11
R 93 4.38 52 31 7
Insula 13 L 2.62 52 4 7
R 3.55 38 11 18
Temporal gyrus 21 L 33 4.15 61 11 14
R 62 3.84 61 7 21
L 16 3.74 67 34 4
R 115 3.84 58 27 7
38 L 52 4.01 40 5 21
R 26 3.94 40 9 25
37 L 59 3.85 58 67 0
R 114 4.05 52 56 11
Precuneus 7 L/R 62 3.67 7 65 32
Fusiform gyrus 19 L 10 3.39 47 67 18
R 65 4.01 47 70 14
37 R 32 4.06 47 45 25
Occipital gyrus 18 L 60 4.20 36 92 11
R 178 4.21 31 97 4
Amygdala 34 L 39 3.87 23 0 21
R 20 3.59 23 4 18
Caudate — L 17 3.50 7 7 0
Putamen — L 52 3.19 18 14 0
R 96 3.35 22 7 4
BA, Brodmann area; L, left; MNI, Montreal Neurological Institute; R, right.
The statistical map height thresholds were Po0.001 for the main effect and Po0.005 for the control–patients comparison. Both maps used an extent
threshold of kE=10.
Unbolded values do not survive small volume correction for multiple comparisons at P (Family-Wise Error; FWE)o0.05 but are included because the
activation is bilateral.
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brain for processing disgust, responding to both disgusted
expressions in others and to pictures eliciting disgust in
subjects (Wicker et al., 2003).
Critically, we observed a significant attenuation of
the insula response to disgust in psoriasis patients, in the
absence of any significant differences in fear response.
One possible explanation of this is that psoriasis patients
develop a coping mechanism to protect them from
stressful emotional responses by blocking the processing
of disgusted facial expressions encountered in others. Some
support for this hypothesis comes from the FERT task
results, which show that the psoriasis patients have
impaired ability to recognize disgust, but not other negative
emotions.
There are a number of possible underlying mechanisms of
this effect. The insula has been implicated in stigmatization
judgments (Krendl et al., 2006), which may relate to the
stigmatization experiences of psoriasis patients (Wahl et al.,
2002; De Korte et al., 2004).
The observed results may also be related to empathy. fMRI
studies have shown that the observation of pain in others is
mediated by the insula as well as by the anterior cingulate
cortex, and these responses are attributed to empathy
(Chakrabarti et al., 2006; de Vignemont and Singer, 2006).
It is therefore possible that the reduced insula response in
psoriasis patients is associated with reduced empathy for
disgust, perhaps resulting from desensitization.
However, psoriasis patients show normal responses to
both disgust and fear in the inferior frontal gyrus, temporal
gyrus and amygdala, which are other areas that play key roles
in social cognition and empathy (Iacoboni and Dapretto,
2006). An impairment in empathy would probably be
associated with abnormal functional responses in these
regions as well as in the amygdala, although it is possible
Table 3. Maximally activated voxels in areas in which
significant evoked activity was related to the covert
recognition of fearful faces blocks compared with the
recognition of neutral faces blocks
Main effect (controls + patients)
MNI coordinates (mm)
Region BA LR Z-score x y z
Lateral orbitofrontal cortex 47 L 3.97 40 25 18
R 3.27 50 32 14
Fusiform gyrus 37 L 3.84 36 86 14
R 4.61 22 79 18
Temporal pole 38 L 3.79 32 16 32
R 3.37 38 22 28
Occipital cortex 18 L 4.37 27 94 0
R 3.97 40 90 4
Amygdala L 3.62 18 5 25
R 2.76 23 2 18
BA, Brodmann area; L, left; MNI, Montreal Neurological Institute; R, right.
Statistical maps were thresholded at Po0.001. Bilateral observations
reported at a lower significance if observed.
1Bold values indicate below threshold but are included because the
activation appears bilateral.
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Figure 1. Reduction of BOLD signal in bilateral insula of psoriasis patients
for processing of disgust. Thirteen right-handed male patients with chronic
plaque psoriasis and 13 age-matched right-handed male controls were
recruited to the study. All participants were tested using a covert recognition
of faces task performed while Philips 3.0 Tesla MR images were acquired.
Participants were presented with A, neutral; B, 100% disgusted; and C, 100%
fearful facial expressions of emotion in a traditional block design, i.e.,
ABACABACABAC. The total task duration was 6minutes and 45 seconds.
Participants were instructed to identify whether the faces were male or female
and make a button box response accordingly. (a) Bilateral insula activation in
psoriasis patients is depicted. (b) The results are shown as percentage BOLD
signal change per group derived from random effects analysis, using a two-
sample t-test, for disgust. Error bars reflect 90% confidence interval. Psoriasis
patients had significantly (Po0.005) smaller BOLD signal responses as
compared with healthy controls.
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Figure 2. The odds of controls detecting facial expressions of disgust across
all disgust intensities is twice as likely than for patients with psoriasis. The
facial expression recognition Task (FERT), a decision-making task, conducted
outside the scanner was used to assess the ability to recognize overtly, facial
expressions of disgust at different intensities. Results are shown as numbers
of correct responses as a function of intensity of disgust (a) and fear (b).
Points are slightly offset to improve clarity (levels were 20, 30, 50, and 70%).
The lines show the fitted mixed logistic regression fits to the data in each
group. (a) Psoriasis patients showed fewer correct responses across all disgust
intensities. (b) The difference between the groups in terms of processing facial
expressions of fear is very small and the lines are almost co-incident.
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that a more explicit test of empathy would be required to
detect subtle abnormalities.
In terms of PASI scores, patients with psoriasis were
categorized as having mild or moderate chronic plaque
psoriasis. Despite the limitations of the PASI (Marks et al.,
1989; Ashcroft et al., 1999; Feldman and Krueger, 2005),
these scores give an indication that our sample of patients
with psoriasis was not confined to those with the most severe,
treatment-resistant form of disease (PASI420). For the
purpose of this study, we did not focus on or sub-stratify
the group into those with psoriasis on exposed versus
nonexposed areas, as we wanted to determine whether there
was a difference per se between the patients with psoriasis
and healthy volunteers. Furthermore, we did not observe a
correlation between PASI score and neural response in the
pre-hypothesized areas.
Consistent with earlier studies, socially anxious indivi-
duals were excluded because it is known that anxiety may
influence processing of facial expressions of emotion in terms
of reaction time to stimuli and brain regions activated
(Phillips et al., 1997; Del-Ben et al., 2005). However, there
was a nonsignificant trend for higher HADS anxiety and
depression scores among patients with psoriasis as compared
with controls. Our small sample has limited power to show
statistical significance and it is therefore possible that the
patients may have sub-syndromal psychological morbidity.
Furthermore, we recruited male patients, and it is possible
that psychological morbidity is enhanced in female patients
and this may be associated with different patterns of brain
response to emotional faces. Further research is needed to
clarify this issue.
In conclusion, the specific insula dysfunction observed in
this study provides a biologically plausible basis for observed
psychological associations of psoriasis. This first application
of fMRI to abnormalities of emotional processing in chronic
skin disease suggests that it may provide previously un-
reported insights into the brain–skin axis. Such insights could
generate new strategies for managing stigmatizing skin
diseases.
MATERIALS AND METHODS
Clinical protocol
The study protocol was approved by an independent local research
ethics committee (Salford and Trafford, Manchester, UK) and the
Declaration of Helsinki protocols were followed.
Volunteers were recruited and interviewed over a 13-month
period from July 2006 to August 2007. The study was performed in
healthy volunteers, who responded to local advertisement at The
University of Manchester and Salford Royal Hospital, and patients
with psoriasis who attend a specialist Psoriasis Clinic (Salford Royal
Hospital, Manchester, UK). All volunteers had to comply with
inclusion and exclusion criteria that, briefly, included (i) age
between 18 and 45 years, (ii) right-handed, (iii) male, (iv) nonsocially
anxious, (v) not taking psychotropic medication, (vi) no contra-
indications to fMRI scanning (below), and (vii) presented no history
of severe or enduring mental or neurological illness.
All prospective participants were screened for social anxiety, using
the fear of negative evaluation, preenrollment to the study (below).
On the day of testing, following written, witnessed, informed
consent, all participants had a clinical assessment that included a full
medical history, to evaluate suitability for undergoing an fMRI scan,
and skin examination. Contraindications to having a brain scan
included (i) the presence of a cardiac pacemaker, (ii) previous
cardiac or brain surgery, (iii) a history of a penetrating eye injury
involving metal, and (iv) any surgery within 2 months of the study
participation.
Participants were instructed how to prosecute the task and underwent
B7minutes of testing within the MR scanner followed by a 6-minute
structural brain scan. Thereafter, participants completed a VAS to record
level of anxiety experienced by undergoing the fMRI scan.
Imaging experimental design
The covert recognition of faces task was performed while
Philips (Eindhoven, Holland) 3.0 Tesla MR brain images were
acquired (TR (repetition time)¼ 5 seconds, 3.5mm thickness
with an in-plane resolution of 1.8 1.8mm, TE (echo time)¼ 37
mseconds). Participants were presented with A, neutral; B, 100%
disgusted; and C, 100% fearful facial expressions of emotion (Ekman
and Friesen, 1976) in a traditional block design, that is, ABACABA-
CABAC. These emotions had been selected from the full set of face
emotions on the basis of their signaling different negative emotions
related to immediate aversive environmental situations (Del-Ben
et al., 2005). The total task duration was 6minutes and 45 seconds,
each block lasted 33.75 seconds and comprised nine pictures of the
appropriate emotion, each presented for 3 seconds with an
interstimulus interval of 0.75 seconds. Participants were instructed
to identify whether the faces were male or female (Phillips et al.,
1997). They were neither asked to examine the facial expression nor
to make a decision on the emotions expressed. The task was back
projected on to a screen visible to the participant through two
mirrors attached to the head coil. Responses were given through a
fiber-optic button box, using the right hand. A T1-weighted structural
image was also acquired for each participant to exclude any
structural abnormalities. No abnormalities were reported for any of
the 26 participants.
FERT
The FERT, adapted from Harmer et al., tested four intensities of
disgust (20, 30, 50, and 70%). Fear and sadness were included as
aversive controls. In the main task, 108 stimuli (9 actors  3 facial
expressions  4 intensities) were each presented for 0.5 seconds
(interstimulus interval¼ 4 seconds).
Psychometric assessments
Fear of negative evaluation scale. This 30-item scale provides
an assessment of worries and fears of rejection. It has been shown
to discriminate between patients with social anxiety and both
non-patient controls and patients with other anxiety disorders
(Rodebaugh et al., 2004). Respondents are instructed to tick ‘‘true’’
or ‘‘false’’ for each question. Each item is scored on a 0–1 scale,
1 being assigned to a response that indicates anxiety. A maximum
total score of 30 may be achieved. Potential volunteers who scored
420 were not included in the study.
HADS. The HADS was originally developed to detect anxiety
and depression among patients with physical illnesses, and the
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depression scale is constructed to minimize the effect of somatic
disorders in the identification of depression (Zigmond and Snaith,
1983). Patients are requested to tick the response to the statement
most relevant to them. The 14 items, each being scored on a 0- to
3-point scale, measure degrees of anxiety (seven items) and
depression (seven items). The two subscale scores thus range from
0 to 21. A score of 8–10 suggests a possible psychological disorder,
whereas scores of 11–21 indicates a probable psychological disorder
on each of the subscales (Richards et al., 2004).
Clinical assessment
PASI. PASI is a widely used measure of physical psoriasis severity. It
is a composite score ranging from 0 to a theoretical maximum of 72
(Fredriksson and Pettersson, 1978). However, a composite PASI
score ofp10 is, by convention, considered to be mild disease; PASI
score between 10 and 20 would be described as moderate disease;
and a PASI score of420 is regarded as severe disease (Feldman and
Krueger, 2005).
Data handling and statistical analysis
Imaging analysis. Imaging data were analyzed using Statistical
Parametric Mapping (SPM5, The Wellcome Department of Cognitive
Neurology, London, UK, http://www.fil.ion.ucl.ac.uk/spm), with a
random effects model. Images were realigned to correct for
motion artifacts using the first scan as a reference and normalized
into the Talairach and Tournoux stereotactic space using Montreal
Neurological Institute templates. The images were then smoothed.
After this spatial preprocessing, first-level analysis was carried out
on each participant to generate a single mean image corresponding
to each aversive face block minus the neutral face block. Motor
responses are matched in the experimental conditions and
neuronal responses to button presses are therefore subtracted out
of the analysis. The mean images for each participant were
then combined in a second-level, random effects analysis, using
a two-sample t-test for each emotion to investigate the main
effect of the aversive emotion versus neutral regardless of group as
well as of the regional BOLD response differences between the
two groups.
Statistical maps were thresholded at Po0.01 uncorrected with a
cluster size of 10 voxels, and voxels with Po0.001 uncorrected
(Z-score 43.09) were reported. When bilateral activations were
seen, lower levels of significance are reported.
Psychometric and VAS analysis. The statistical significance of
differences of psychometric (fear of negative evaluation, HADS) and
VAS scores between controls and patients was evaluated using the
independent t-test (SPSS Software, SPSS, Chicago, IL).
FERT analysis. A mixed logistic model was fitted to the number
of correct responses, treating these as binomial outcomes, with
a random effect to allow for variability between participants
(R Development Core Team Software, Vienna, Austria). The results
are presented as odds ratios for the difference between groups and
plots of the fixed effects. Significance is determined using likelihood
ratio tests.
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